LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Strona główna・Stock List・Illumina Inc

Search

Illumina Inc

Closed

Sector Healthcare

124.18 -4.18

Overview

Share price change

24h

Current

Min

123.96

Max

125.38

Key metrics
By Trading Economics
Income	-1.9B -2B
Sales	30M 1.1B
EPS	0.36
Profit margin	-179.099
Employees	10,590
EBITDA	-1.9B -1.9B

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+20.11 upside

Dividends
By Dow Jones
Next Earnings	7 lis 2024

Market Stats
By TradingEconomics
Market Cap	21B
Previous open	128.36
Previous close	124.18

News Sentiment

By Acuity

48%

52%

107 / 365 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

N/A / 130.15 Support & Resistance

Illumina Inc Chart

Related News

11 gru 2023, 18:43 UTC

Acquisitions, Mergers, Takeovers

Illumina Submits SEC Form For Grail Divestiture

13 paź 2023, 18:42 UTC

Acquisitions, Mergers, Takeovers

Illumina Gets European Commission Order to Divest Grail

5 mar 2024, 08:00 UTC

Earnings

Earnings Season Is Wrapping Up. Who Came Out Ahead, in 6 Charts. -- Barrons.com

18 gru 2023, 23:17 UTC

Acquisitions, Mergers, Takeovers

Antitrust Regulators Issue New Merger Rules Amid Crackdown -- Barrons.com

18 gru 2023, 20:33 UTC

Acquisitions, Mergers, Takeovers

Adobe-Figma Breakup Isn't Just a Win for Regulators. Why Consumers Should Be Cheering Too. -- Barrons.com

18 gru 2023, 09:48 UTC

Acquisitions, Mergers, Takeovers

Illumina to Sell Grail. It's Giving Up on its Biotech Antitrust Battle. -- Barrons.com

18 gru 2023, 09:34 UTC

Acquisitions, Mergers, Takeovers

These Stocks Are Moving the Most Today: Illumina, Roku, Uber, Broadcom, and More -- Barrons.com

9 lis 2023, 09:39 UTC

Earnings

These Stocks Are Moving the Most Today: Disney, Arm, Applovin, Affirm, Topgolf Callaway, and More -- Barrons.com

Peer Comparison

Price change

Illumina Inc Forecast

Price Target

By TipRanks

20.11% upside

12 Months Forecast

Average 149.4 USD 20.11%

High 242 USD

Low 105 USD

Based on 20 Wall Street analysts offering 12 month price targets forIllumina Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

20 ratings

12

Buy

7

Hold

1

Sell

Based on 20 analysts giving stock ratings to Illumina Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 130.15Support & Resistance

Recent bearish events outweigh bullish events.

All events are bullish.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

107 / 365 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Illumina Inc

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.

Other stocks from the sector

LLY

Eli Lilly and Co.

902.74

UNH

UnitedHealth Group Inc

596.8

NVO

Novo Nordisk A-S

131.05

JNJ

Johnson and Johnson

164.37

ABBV

AbbVie Inc

193.18